Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Comment by wildbird1on Dec 30, 2024 12:12pm
203 Views
Post# 36380970

RE:Treating all patients, all comers.

RE:Treating all patients, all comers.Maxitrac you have been on this board for a very short time, and I thanks you for your contribution.

Your post was was a very good post. It also gave me a chance to check the latest Corporate Presentation.

You must understand that some posters will grab any chance to discredit TLT.

Personnaly, I understood that the underlined part of your post was from TLT.
The rest was from you, and most peoples on this board did understand the same as me.

Why tdon1229 choose to attack TLT, on a false affirmation that wasn't there in the first place, only tdon1229 can answer why.

Maxcitrac wrote: If you look at these two Corporate presentation you will notice something that went almost unnoticed.
Theralase-Corporate-Presentation-03-19-2024.pdf
March 18 2024
89% of patients treated have received over 7 previous BCG treatments.
Theralase-Corporate-Presentation-12082024.pdf
Dec 8 2024

95% of patients treated have received over 7 previous BCG treatments.
Theralase is treating more and more patients that have received over 7 BCG treatments.
This is an indication that Theralase is not afraid to treat more heavily pretreated patients.
Could also indicate that Theralase is getting better and better at treating all patients.
Remember what Theralase did say We treat all patients, all comers, and our data are world class.
No other FDA approved treatment for BCG resistant patients can brag about treating all patients.


<< Previous
Bullboard Posts
Next >>